Effect of Alipogene Tiparvovec (AAV1-LPL S447X ) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients

Carpentier, André C., Frisch, Frédérique, Labbé, Sébastien M., Gagnon, René, de Wal, Janneke, Greentree, Stephen, Petry, Harald, Twisk, Jaap, Brisson, Diane, Gaudet, Daniel·2012·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2011-3002

Cited by (164)

Items 101–164 of 164

  1. Novel Therapeutics for Familial Chylomicronemia Syndrome
    Maria Cristina de Oliveira Izar, Francisco Antônio Helfenstein Fonseca · 2025 · Current Atherosclerosis Reports
  2. Large-Scale Clinical Manufacturing of AAV Vectors for Systemic Muscle Gene Therapy
    Nathalie Clément · 2019 · Springer eBooks
  3. Molecular Genetic Markers as a Basis for Personalized Medicine / MOLEKULARNO-GENETIČKI MARKERI KAO OSNOV ZA PERSONALIZOVANU MEDICINU
    Sonja Pavlović, Branka Zukić, Stojiljković-Petrović Maja · 2013 · Journal of Medical Biochemistry
  4. Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application
    H. Mohamed, Yuti Chernajovsky, David Gould · 2016 · Scientific Reports
  5. An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice
    Quan Jin, Chunping Qiao, Jianbin Li, Juan Li, Xiao Xiao · 2019 · Gene Therapy
  6. Hypertriglyceridemia Associated With Abdominal Obesity
    André C. Carpentier · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
  7. AAVR-Displaying Interfaces: Serotype-Independent Adeno-Associated Virus Capture and Local Delivery Systems
    Seung‐Hyun Kim, Slgirim Lee, Heehyung Lee, Mira Cho, David V. Schaffer, Jae‐Hyung Jang · 2019 · Molecular Therapy — Nucleic Acids
  8. New and Future Parenteral Therapies for the Management of Lipid Disorders
    Roberto Rodríguez García, Jaime Burkle · 2018 · Archives of Medical Research
  9. Cardiac regenerative medicine: At the crossroad of microRNA function and biotechnology
    Andrea Raso, Ellen Dirkx · 2017 · Non-coding RNA Research
  10. Contemporary and Novel Therapeutic Options for Hypertriglyceridemia
    Damon A. Bell, Gerald Francis Watts · 2015 · Clinical Therapeutics
  11. Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application
    Neel Mehta, Rénald Gilbert, Parminder S. Chahal, María Moreno, Nasha Nassoury, Nathalie Coulombe, Richard Gingras, Alaka Mullick, Simon Drouin, Marc Sasseville et al. · 2025 · Gene Therapy
  12. Lipoprotein lipase isoelectric point isoforms in humans
    Míriam Badia-Villanueva, Pere Carulla, Montserrat Carrascal, Joaquín Abián, Miquel Llobera, Albert Casanovas, Maria Dolores López-Tejero · 2014 · Biochemical and Biophysical Research Communications
  13. A Novel Approach to the Treatment of Plasma Protein Deficiency: Ex Vivo-Manipulated Adipocytes for Sustained Secretion of Therapeutic Proteins
    Masayuki Kuroda, Yasushi Saitō, Masayuki Aso, Koutaro Yokote · 2018 · Chemical and Pharmaceutical Bulletin
  14. Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine
    Nolwenn Tessier, Fatma Moawad, Nada Amri, Davide Brambilla, Catherine Martel · 2021 · Pharmaceutics
  15. Nucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming
    Hannia V. Balcorta, Veronica Guerrero, Deepali Bisht, Wilson Poon · 2024 · ACS Applied Bio Materials
  16. Critical review of non-statin treatments for dyslipoproteinemia
    Jing Pang, Dick C. Chan, Gerald Francis Watts · 2014 · Expert Review of Cardiovascular Therapy
  17. Augmenting PBGD Expression in the Liver as a Novel Gene Therapy for Acute Intermittent Porphyria (AIPgene)
    2014 · Human Gene Therapy Clinical Development
  18. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction
    Guang‐Feng Zuo, Liguo Wang, Lu Huang, Yifei Ren, Zhen Ge, Zuo‐Ying Hu, Junjie Zhang, Shao‐Liang Chen · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  19. Prospective therapeutic approaches in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
    Raquel Cabrera-Pérez, Javier Torres‐Torronteras, Ferran Vila‐Julià, Francisco José Ortega, Yolanda Cámara, Jordi Barquinero, Ramón Martí · 2015 · Expert Opinion on Orphan Drugs
  20. Moving Forward Toward a Cure for Hemophilia B
    Thierry VandenDriessche, Marinee Chuah · 2015 · Molecular Therapy
  21. Schwere Hypertriglyzeridämie
    Ursula Kassner, Michaela Dippel, Elisabeth Steinhagen‐Thiessen · 2017 · Der Internist
  22. Advancing Gene Therapy for Pancreatitis: From Genetic Insights to Clinical Translation
    Yi-Zhou Zheng, Yuan‐Chen Wang, Hang-Ming Qi, Jie Gao, Zhao‐Shen Li, Zhuan Liao, Wen‐Bin Zou · 2026 · Research
  23. A highly mobile adeno-associated virus targeting vascular smooth muscle cells for the treatment of pulmonary arterial hypertension
    Yoojin Kim, Yeongju Yeo, Min Ju Kim, Yong-Wook Son, Joowon Kim, Koung Li Kim, Seohee Kim, Seokmin Oh, Yunha Kim, Hyowoo Lee et al. · 2025 · Nature Biomedical Engineering
  24. Adeno-associated Virus as a Mammalian DNA Vector
    Max Salganik, Matthew Louis Hirsch, Richard Jude Samulski · 2015 · ASM Press eBooks
  25. An update on gene therapy for the treatment of lipoprotein lipase deficiency
    Hong Wang, Andrew E. Libby · 2014 · Orphan Drugs Research and Reviews
  26. Viral Vectors for Gene Therapy
    James N. Warnock, Mohamed Al‐Rubeai · 2014 · Encyclopedia of Industrial Biotechnology
  27. Acute pancreatitis in pregnancy and familial chylomicronemia syndrome: case report and literature review
    Batoul Jaafar, Jessica Abou Chaaya, Shahed Ammar, Ibrahim Salti · 2023 · Metabolism and Target Organ Damage
  28. Missing Regulation Between Genetic Association and Transcriptional Abundance for Hypercholesterolemia Genes
    Aaron Hakim, Noah J Connally, Gavin R. Schnitzler, Michael Cho, Zhenghui Gordon Jiang, Shamil R. Sunyaev, Rajat M. Gupta · 2025 · Genes
  29. AAV shuffles to the liver: commentary on Lisowski et al.
    David V. Schaffer · 2014 · Molecular Therapy — Methods & Clinical Development
  30. Viral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges
    Jean‐Simon Diallo · 2019 · Elsevier eBooks
  31. Tratamiento de la quilomicronemia
    Alicia Navarro Hermoso, Pedro Valdivielso · 2021 · Clínica e Investigación en Arteriosclerosis
  32. The application of gene therapy in lipid disorders: where are we now?
    Joseph B. Dubé, Robert Alexander Hegele · 2012 · Clinical Lipidology
  33. Adeno-Associated Virus Gene Therapy and Its Application to the Prevention and Personalised Treatment of Rare Diseases
    Konstantina Grosios, Harald Petry, Jacek Lubelski · 2014 · Advances in predictive, preventive and personalised medicine
  34. Gene Therapy in Articular Cartilage Repair
    Alan Ivković, Andreja Vukasović, Ryan M. Porter, Damir Hudetz, Marko M. Pecina, Christopher H. Evans · 2013 · Springer eBooks
  35. Gene Therapy
    Alireza Shahryari, Zahra Nazari, Marie Saghaeian Jazi, Fatemeh Hashemi-Shahraki, Katharina Wißmiller, Weiwei Xu, Ingo Burtscher, Heiko Lickert · 2022 · Elsevier eBooks
  36. Special Patient Populations
    Daniel Gaudet · 2023 · Elsevier eBooks
  37. Letter to the Editor: “Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline”
    Yasuhiro Naiki, Maki Fukami · 2018 · The Journal of Clinical Endocrinology & Metabolism
  38. New era in gene therapy: end of the beginning
    Ryuichi Morishita · 2015 · Expert Opinion on Biological Therapy
  39. Stimulation of AAV Gene Editing via DSB Repair
    Angela M. Mitchell, Rachel J. Moser, Richard Jude Samulski, Matthew Louis Hirsch · 2016 · Advances in experimental medicine and biology
  40. Investigated treatments for lipoprotein lipase deficiency and related metabolic disorders
    Joo-Ho Lee, Robert Alexander Hegele · 2017 · Expert Opinion on Orphan Drugs
  41. Advances in Hypercholesterolemia
    Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano · 2016 · Elsevier eBooks
  42. Immune Responses to Adeno-Associated Virus-Mediated CRISPR Therapy
    Allison M. Keeler · 2021 · Human Gene Therapy
  43. Use of Avian Adeno-Associated Virus for the Delivery of Transgenes to Pekin Duck Cells in vitro and in vivo
    Carleigh R. Robinson, Gregory Scott Fraley, Benjamin G. Kopek · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Klinische Befunde und rationelle Differenzialdiagnostik der diabetischen Dyslipidämie
    Arnold von Eckardstein · 2012 · Der Diabetologe
  45. Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies
    Sophie J. Bernelot Moens, Carlijne Hassing, Max Nieuwdorp, Erik S.G. Stroes, Geesje M. Dallinga‐Thie · 2013 · Clinical Lipidology
  46. Identification de biomarqueurs de risque à la pancréatite aigüe récurrente dans l’hyperchylomicronémie familiale
    Camélia Dubois-Bouchard · 2014
  47. Modulation of adeno-associated virus transduction by the promyelocytic leukemia protein, arsenic trioxide, and proteasome inhibitors
    Angela M. Mitchell · 2013 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  48. The Role of Assembly-Activating Protein in the Capsid Assembly of Different Adeno-Associated Virus Serotypes
    Lauriel F. Earley · 2016
  49. Breakthroughs and barriers in clinical gene therapy
    Katharine J. Liang, John Paul Gaylor, Richard Jude Samulski · 2015
  50. UNCOVERING STRUCTURAL COMPONENTS OF THE ADENO-ASSOCIATED VIRAL CAPSID THAT CAN BE MODIFIED TO IMPROVE CLINICAL GENE THERAPY OUTCOMES
    Jayme K. Warischalk · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  51. Engineering of Novel Adeno-Associated Virus Vectors for Gene Therapy Applications
    Santiago Ortiz, Jorge Luis · 2016
  52. Understanding mechanisms of Adeno-associated virus vector transduction through pharmacological and biological approaches
    Sarah C. Nicolson · 2014 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  53. AAV-Nrf2 Mediated Rescue of Oxidative Stress in Mouse Models
    Katharine J. Liang · 2015 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  54. Viral Gene Delivery
    Basma N. Abd El‐Hamid, Ikramy A. Khalil, Hideyoshi Harashima · 2021 · Springer eBooks
  55. Viral Gene Delivery
    Basma N. Abd El‐Hamid, Ikramy A. Khalil, Hideyoshi Harashima · 2022 · Springer eBooks
  56. Advanced Therapies for Patients with COVID-19
    Tatiana Maron‐Gutierrez, Miquéias Lopes‐Pacheco, Patrícia R. M. Rocco · 2023 · Interdisciplinary biotechnological advances
  57. Hypertriglyceridemia: diagnostic issues, therapeutic strategies
    V. V. Bakaleiko, O. V. Reutova, М. С. Алиева, G. G. Baratashvili, Anna Aleksandrovna Kostareva, Asiiat S. Alieva · 2024 · Russian Journal for Personalized Medicine
  58. Literaturverzeichnis
    2022 · Elsevier eBooks
  59. Neurogenetik
    Christiane Michaela Neuhofer, Thomas Gasser, Thomas Klopstock · 2022 · Elsevier eBooks
  60. The co-delivery of Programmed Death 1 ligands enhances and prolongs rAAV-mediated gene expression in pre-immunized mice
    Piia Käyhty, Tiina Nieminen, Reetta A. E. Eriksson, Ritva Tumelius, Ahmed Tawfek, Svetlana Laidinen, Anna‐Kaisa Ruotsalainen, Aubrey Bailey, Lionel Galibert, Hanna P. Lesch et al. · 2026 · Gene Therapy
  61. Characterisation of AAV capsid-specific CD8+ T cell responses in human subjects
    Céline Vandamme · 2016 · theses.fr (ABES)
  62. Treatment of severe hypertriglyceridemia: a new era dawns
    Miriam Larouche, Daniel Gaudet · 2026 · The Journal of Clinical Endocrinology & Metabolism
  63. Shifting AAV9 tropism by binding moiety insertion enhances transduction of tumor cell lines and human glioblastoma explants
    Claire Rothschild‐Gronau, Philipp Borchert, Marco T. Radukic, Lucas Haverkamp, Roland Coras, Matthias Simon, Kristian M. Müller · 2026 · Scientific Reports
  64. Gene therapy for rare diseases: technological innovation and clinical translation
    Ying-Jie ZHANG, Huijun Yuan · 2026 · Shengming kexue